This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Reduction of Hypertrophic Skin Scarring
and you are
between 18 and 55
years old
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The study will compare how well PF-06473871 works versus placebo in reducing skin scarring after scar revision surgery of existing breast scars. The study will also evaluate the safety of PF-06473871 in healthy adult subjects.

Provided treatments

  • Drug: PF-06473871
  • Drug: PF-06473871
Tris trial is registered with FDA with number: NCT01730339. The sponsor of the trial is Pfizer and it is looking for 103 volunteers for the current phase.
Official trial title:
A Phase 2, Randomized, Double-blind, Within-subject, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Pf 06473871 In Reducing Hypertrophic Skin Scarring